Data as of Dec 18
| +0.02 / +0.15%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 10.00. The median estimate represents a +4.17% increase from the last price of 13.44.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.